血必净联合抗生素治疗老年人脓毒症临床疗效分析
山西省中西医结合医院
目的 探究血必净联合抗生素方案对老年脓毒症患者血流动力学、炎症免疫及器官功能的影响。方法选取2021年1月至2025年1月本院收治的80例老年脓毒症患者为研究对象,采用随机数字表法分为对照组(40例)与观察组(40例)。对照组给予常规抗生素抗感染及对症支持治疗,观察组则在上述方案基础上加用血必净注射液。对比两组患者的临床症状恢复时间、血流动力学指标、血清炎症因子水平、免疫功能指标、病情严重度及器官功能状态。结果 治疗后,相较于对照组,观察组临床症状恢复时间更短,血流动力学指标变化幅度更明显,血清炎症因子水平更低,免疫功能指标更高,急性生理与慢性健康状况评价(APACHE Ⅱ)和全身感染器官功能障碍(SOFA)评分下降更显著(P<0.05)。结论 血必净联合抗生素治疗老年脓毒症,不仅有助于稳定患者的血流动力学状态,还能有效下调炎症因子水平、改善免疫指标,从而对器官功能起到保护作用,该方案疗效确切且安全可靠,值得临床推广。
Objective To explore the effects of Xuebijing combined with antibiotic therapy on the hemodynamics, inflammatory immunity, and organ functions of elderly patients with sepsis. Methods A total of 80 elderly patients with sepsis treated in our hospital from January 2021 to January 2025 were selected as the research subjects. They were randomly divided into the control group(40 cases) and the observation group(40 cases) using a random number table. The control group received conventional antibiotic anti-infection and symptomatic supportive treatment, while the observation group was treated with the above-mentioned regimen in addition to Xuebijing injection. The clinical symptom recovery time, hemodynamic indicators, serum inflammatory factor levels, immune function indicators, severity of the disease, and organ function status of the two groups were compared. Results After treatment, the clinical symptom recovery time of the observation group was shorter, the changes in hemodynamic indicators were more significant, the serum inflammatory factor levels were lower, the immune function indicators were higher, and the Acute Physiology and Chronic Health Evaluation(APACHE Ⅱ) and Systemic Infection Organ Dysfunction(SOFA) scores decreased more significantly(P<0.05). Conclusion The combined use of Xuebijing and antibiotics in the treatment of elderly sepsis not only helps to stabilize the hemodynamic state of patients, but also effectively reduces inflammatory factor levels, improves immune indicators, thereby protecting organ functions. This treatment scheme is effective and safe, and is worthy of clinical promotion.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 10 条- [1]邢广贺.血必净注射液调控NLRP3炎症小体通路改善脓毒症炎症反应的机制研究[D].天津中医药大学,2025.
- [2]郑鹏肖.血必净注射液联合低分子肝素治疗脓毒症患者的动态作用分析[D].吉林大学,2024.
- [3]周页芬,吴海峰,陆俊杰,等.血必净注射液联合利奈唑胺治疗脓毒症的临床研究[J].现代药物与临床,2023,38(11):2792-2796.
- [4]孙啸宇,陆宗庆,张金,等.《拯救脓毒症运动:脓毒症与脓毒性休克治疗国际指南(2021)》摘译与解读[J].中国中西医结合急救杂志,2021,28(6):645-652.
- [5]中华医学会重症医学分会.中国成人脓毒症诊断与治疗指南(2023)[J].中华重症医学电子杂志,2023,9(1):1-36.
- [6]修丽梅,杨飞,陈壮.血必净注射液在烧伤脓毒症治疗中的应用[J].中国实用医药,2021,16(26):18-20.
- [7]刘宁湘,周荣.血必净联合美罗培南治疗脓毒症的临床效果及对炎性因子和免疫功能的影响[J].临床合理用药,2025,18(31):18-21.
- [8]张华,沈洁.血必净联合利奈唑胺治疗脓毒症的效果及对患者心输出量和炎症因子水平的影响[J].中国药物经济学,2025,20(9):52-55.
- [9]牛丹,李博玲,张怡.连续性血液净化联合血必净对脓毒症的疗效及对血清SAA和CRP及PCT水平的影响[J].热带医学杂志,2023,23(9):1256-1260.
- [10]韩文君,李晓凡,李欣,等.血必净联合乌司他丁对老年脓毒症患者多器官保护作用[J].临床误诊误治,2025,38(22):83-89.
| 文章编号 | 2026-05-032(期号内编号) |
|---|---|
| 栏目 | 临床药物与手术治疗 |
| 作者 | 潘虹 |
| 作者单位 | 山西省中西医结合医院 |
| 中图分类号 | R459.7 |
| 卷期页码 | 2026, 2(05): 125-128 |
| 发布时间 | 2026-08-15 |
| 出版时间 | 2026-08-15 |
| 引用信息 | [1]潘虹.血必净联合抗生素治疗老年人脓毒症临床疗效分析[J].疾病预防与控制,2026,2(05):125-128. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-09-22T12:08:18 |